Bio-FD&C Co

Bio-FD&C Co FCF Conversion

The FCF Conversion Rate (FCF/EBITDA) of Bio-FD&C Co (251120.KQ) as of Nov 14, 2026 is 93.46 %. In the previous year, FCF Conversion Rate (FCF/EBITDA) was 105.33 % — a change of -11.27% (lower).

FCF Conversion

93.46 %

YoY

-11.27%

Last updated:

FCF Conversion Rate (FCF/EBITDA) of Bio-FD&C Co is 2025 93.46 % . FCF Conversion Rate (FCF/EBITDA) of Bio-FD&C Co was 2024 105.33 % . It decreases by -11.27% lower compared to the previous year.

The Bio-FD&C Co FCF Conversion history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

FCF Conversion
Date
FCF Conversion
Jan 1, 2018
-14.64 KRW
Jan 1, 2019
114.92 KRW
Jan 1, 2020
9.30 KRW
Jan 1, 2021
-114.54 KRW
Jan 1, 2022
125.04 KRW
Jan 1, 2023
66.56 KRW
Jan 1, 2024
105.33 KRW
Jan 1, 2025
93.46 KRW
The Bio-FD&C Co FCF Conversion history
YEARFCF ConversionYoY
93.46 %-11.27%
105.33 %+58.25%
66.56 %-46.77%
125.04 %-209.17%
-114.54 %-1,332.22%
9.30 %-91.91%
114.92 %-884.74%
-14.64 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Bio-FD&C Co Stock analysis

What does Bio-FD&C Co do? Bio-FD&C Co., Ltd. develops bio and health technologies, focusing on manufacturing and selling soybean callus culture extract, clock stem cell, centella asiatica, callus extract, aloe barbadensis phytoplaceta extract, prunus mume phytoplacenta extract, secale cereale adventitious root extract, and acanthopanax koreanum adventitious root culture extract. These products serve as key materials for cosmeceuticals, health functional foods, and pharmaceuticals, targeting companies in the cosmetics, health supplement, and pharmaceutical industries. The company generates revenue through direct sales of these specialized extracts to manufacturers who incorporate them into their final products. The firm's product portfolio includes unique bioactive compounds like centella asiatica and prunus mume phytoplacenta extract, which are used in high-value applications within the cosmeceutical and pharmaceutical sectors. By supplying these specialized ingredients, Bio-FD&C Co., Ltd. caters to clients seeking natural, plant-based solutions for product development. Its focus on extract-based materials positions it as a supplier for companies developing innovative health and beauty products. Bio-FD&C Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Bio-FD&C Co stock

FCF Conversion Rate (FCF/EBITDA) of Bio-FD&C Co is 93.46 % in 2025.

FCF Conversion Rate (FCF/EBITDA) of Bio-FD&C Co changed from 105.33 % to 93.46 %, representing a -11.27% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of FCF Conversion Rate (FCF/EBITDA) Bio-FD&C Co since 2006 – with annual values, charts, and detailed analysis.

FCF conversion measures how effectively EBITDA converts to free cash flow. Higher conversion indicates efficient capital allocation and low maintenance costs.

A 'good' varies by industry and company stage. On Eulerpool, you can compare FCF Conversion Rate (FCF/EBITDA)'s Bio-FD&C Co with sector peers and the industry average to assess whether it is attractive.

To evaluate FCF Conversion Rate (FCF/EBITDA)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for FCF Conversion Rate (FCF/EBITDA).

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Cash Flow — Bio-FD&C Co

Operating Cash FlowCapital ExpendituresFree Cash FlowFCF per ShareDividends PaidShare BuybacksInvesting Cash FlowFinancing Cash FlowCapEx / RevenueCash Flow per ShareStock-Based CompensationChange in Working CapitalAcquisitions (Net)Net Change in CashCapEx/OCFFCF/Net IncomeFCF ConversionCash ConversionTotal Shareholder PayoutCapEx/D&A

All Key Metrics — Bio-FD&C Co